| Dr Brian J Ballard, OD | |
|
300 N Broadway Ave, Riverton, WY 82501-3545 | |
| (307) 856-9451 | |
| (307) 856-8548 |
| Full Name | Dr Brian J Ballard |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 47 Years |
| Location | 300 N Broadway Ave, Riverton, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114919826 | NPI | - | NPPES |
| 104136300 | Medicaid | WY | |
| 0762340001 | Other | WY | CIGNA MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 118T (Wyoming) | Primary |
| Provider Name | Riverton Vision Center P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962494690 PECOS PAC ID: 1052393519 Enrollment ID: O20040607001187 |
News Archive
A survey of patients treated for cancer on the NHS in England shows that blood cancers are still taking longer to be diagnosed than other types of cancer.
Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.
NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.
When a new pathogen wreaks havoc on the planet, scientists from across the globe race to understand how it behaves and spreads. Now, scientists have found that the novel coronavirus (2019-nCoV) can survive on metal, plastic, and glass for as long as nine days.
Emergency Medical Services Corporation today announced that its American Medical Response subsidiary has entered into a new agreement with the State of Idaho to provide non-emergency medical transportation management services for the State's Medicaid beneficiaries.
› Verified 8 days ago
| Provider Name | Dubois Vision Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073505699 PECOS PAC ID: 5799768933 Enrollment ID: O20040609001190 |
News Archive
A survey of patients treated for cancer on the NHS in England shows that blood cancers are still taking longer to be diagnosed than other types of cancer.
Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.
NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.
When a new pathogen wreaks havoc on the planet, scientists from across the globe race to understand how it behaves and spreads. Now, scientists have found that the novel coronavirus (2019-nCoV) can survive on metal, plastic, and glass for as long as nine days.
Emergency Medical Services Corporation today announced that its American Medical Response subsidiary has entered into a new agreement with the State of Idaho to provide non-emergency medical transportation management services for the State's Medicaid beneficiaries.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian J Ballard, OD 300 N Broadway Ave, Riverton, WY 82501-3545 Ph: (307) 856-9451 | Dr Brian J Ballard, OD 300 N Broadway Ave, Riverton, WY 82501-3545 Ph: (307) 856-9451 |
News Archive
A survey of patients treated for cancer on the NHS in England shows that blood cancers are still taking longer to be diagnosed than other types of cancer.
Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.
NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.
When a new pathogen wreaks havoc on the planet, scientists from across the globe race to understand how it behaves and spreads. Now, scientists have found that the novel coronavirus (2019-nCoV) can survive on metal, plastic, and glass for as long as nine days.
Emergency Medical Services Corporation today announced that its American Medical Response subsidiary has entered into a new agreement with the State of Idaho to provide non-emergency medical transportation management services for the State's Medicaid beneficiaries.
› Verified 8 days ago
Mr. James M Hinkle, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 300 N Broadway Ave, Riverton, WY 82501 Phone: 307-856-9451 Fax: 307-856-8548 | |
Dr. Derek Alan Walton, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 400 E Adams Ave, Riverton, WY 82501 Phone: 307-856-3937 Fax: 307-856-1306 | |
Fremont Vision Clinic Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 704 E Fremont Ave, Riverton, WY 82501 Phone: 307-856-9000 | |
Dr. Benjamin J Kister, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 400 E Adams Ave, Riverton, WY 82501 Phone: 307-856-6531 Fax: 307-856-1306 | |
Dr. Shelly Ann Cadman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 704 E Fremont Ave, Riverton, WY 82501 Phone: 307-856-9000 Fax: 307-856-9004 | |
Roberson Resources Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1733 N Federal Blvd, Riverton, WY 82501 Phone: 307-857-4491 |